Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

Papillary Dermis

Papillary Dermis

Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen and...

Hand hygiene

Hand hygiene

Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

3D bioprinting in regenerative medicine: From skin to organ engineering.

Annales de chirurgie plastique et esthetique·2025

Same author

World vitiligo day: a model for grassroots medical activism and pharmaceutical innovation.

Frontiers in medicine·2025

Same author

Mapping the vitiligo patient journey: from awareness to treatment or coping strategies.

Frontiers in rehabilitation sciences·2025

Same author

Evaluating the suitability of granular anammox biomass for nitrogen removal from vegetable tannery wastewater.

Biodegradation·2023

Same author

JEADV - the birth.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Same author

A new Italian chemical peel, based on <i>Oenanthe crocata</i> extract.

Journal of biological regulators and homeostatic agents·2021

Search research articles

Related Experiment Videos

Pimecrolimus in dermatology.

C Fabroni¹, T Lotti

¹Complex Dermatology Unit, University of Florence, Florence, Italy. fabroni@dada.it

Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia

|June 17, 2009

Summary

This summary is machine-generated.

Pimecrolimus, a calcineurin phosphatase inhibitor, effectively treats mild to moderate atopic dermatitis. This non-steroidal immunosuppressant shows potential for various inflammatory skin conditions.

Related Experiment Videos

Area of Science:

Dermatology
Immunology
Pharmacology

Background:

Pimecrolimus is a non-steroidal immunosuppressant derived from ascomycin.
It functions by inhibiting calcineurin phosphatase, thereby blocking inflammatory substance production.
These inflammatory substances are implicated in the pathogenesis of skin lesions in inflammatory diseases.

Purpose of the Study:

To review the therapeutic applications of pimecrolimus in dermatology.
To highlight its approved indications and explore its potential in other inflammatory skin conditions.

Main Methods:

Literature review of pimecrolimus's mechanism of action and clinical applications.
Summary of its approved use in atopic dermatitis and emerging evidence for other dermatoses.

Main Results:

Pimecrolimus 1% cream is approved for mild to moderate atopic dermatitis as a second-line therapy.
It is indicated for short-term, non-continuous chronic treatment in adults and children over 2 years old.
Pimecrolimus demonstrates potential in treating psoriasis, vitiligo, and cutaneous lupus erythematosus.

Conclusions:

Pimecrolimus is an effective topical immunomodulator for atopic dermatitis.
Its immunosuppressive properties suggest broad potential for treating various inflammatory skin diseases.
Further research may solidify its role in managing conditions beyond atopic dermatitis.